Isogenica Nature Webinar: ‘VHH as building blocks for immune and tumour cell-targeting’

Join us for our upcoming webinar with Nature Research Custom Media on ‘VHH as building blocks for immune and tumour cell-targeting’, presented by our CSO Bill Eldridge. ​

This presentation will expand on the recent advances in the field of VHH-based therapeutics and highlight particular therapy applications where a naturally monovalent antibody domain structure can be combined to generate the next generation of biologics.​

Register for the webinar now to learn all about the incredible potential and latest developments of VHH in next generation therapeutics.​
Register here

Contact us